Brief: Allovir Inc - On June 5 Entered Into A Termination Of Sublease Agreement With AMAG Pharmaceuticals, Inc
11/06/2024 23:08
Allovir Inc ALVR.O :
* ALLOVIR INC - ON JUNE 5 ENTERED INTO A TERMINATION OF
SUBLEASE
AGREEMENT WITH AMAG PHARMACEUTICALS, INC
Source text for Eikon: ID:n0001193125-24-159226
Further company coverage: ALVR.O
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million